Prestige BioPharma950210 
$10.621.60%24h
1.60%24h
Global rank10457
Market cap$635.59M
Change 7d-3.80%
YTD Performance59.16%
SP500 benchmarkOutperform
P/E0.04
P/S5620.22
Revenue$113.09K
Earnings-$2.00M
Dividend yield-
Prestige BioPharma (950210) Net Assets
950210 Net Assets in 2023: $546.23B
As of 13 Dec 2024, Prestige BioPharma net assets is $546.23B, an increase of 27.05% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Prestige BioPharma overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Prestige BioPharma Net Assets History from 2020 to 2024
-
Value:-
950210 Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $546.23B | 27.05% |
| 2022 | $429.94B | -25.22% |
| 2021 | $574.96B | 317.24% |
| 2020 | $137.80B | - |
View the Top Net Assets Companies
